Navigation Links
Most Influential Events for Korea's Fine and Specialty Chemical and Pharmaceutical Industries to be Held in November
Date:7/28/2008

SEOUL, South Korea, July 28 /PRNewswire/ -- The one-stop marketplace for the fine and specialty chemical and pharmaceutical industries, XpoChem and XpoPharm, will take place at SETEC in Seoul, South Korea, on 5 and 6 November 2008, exhibiting a wide range of items in these fields, from ingredients and intermediates to finished products, equipment and machinery.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080728/NYM070 )

Since its launch in 2004, XpoChem and XpoPharm have revitalized the fine and specialty chemical and pharmaceutical industries in Korea by providing a professional meeting place for networking and business. The first and only focused events in these industries in Korea, they have also attracted a lot of interest, not only from local companies, but also from overseas companies looking for a way to make inroads into the Korean market. The events show a high rate of foreign exhibitors, at an average of over 60%, for the past four years.

With both local and overseas attention, the events have grown and matured, and exhibitors have expressed their satisfaction. Yong-gil Choi, team leader of Dealim Chemical Co. Ltd., one of the exhibitors in 2007, said, "I was very satisfied with the high level of professional visitors and buyers." Another exhibitor at the 2007 events, Byung-yoon Choi, Assistant Manager of Dongwoo Syntech Co Ltd, said, "We are focused on both the domestic and the overseas markets, and XpoChem and XpoPharm are a good opportunity to meet core buyers." In fact, 73.3% of visitors in 2007 were decision-makers (President/CEO/Team Leader/Manager), and the tendency among exhibitors to re-book a booth on-site and increase their booth size is prominent this year. This atmosphere seems to have been created by loyal exhibitors who have participated in the fairs from the first year, experiencing good business results and promotional effects. '/>"/>

SOURCE CMP Media Korea Co. Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Vickie Milazzo Named to Most Influential List Award Houstons 50 Most Influential Women
2. AIUM CEO named among most influential in radiology
3. LCA-Vision Announces Upcoming Investment Community Events
4. Topical oral syrup prevents early childhood caries
5. Drugs With Marijuana Compounds Dont Boost Adverse Events
6. CVS Caremark Employees Raise $1 Million and Increase Awareness for Children with Disabilities through Easter Seals Walk With Me Events Nationwide
7. Data Published in Plastic and Reconstructive Surgery Show Cohera Medicals Surgical Adhesive, TissuGlu(R), Prevents Seroma Formation in Animal Abdominoplasty Model
8. Rheumatoid arthritis factors equal to cardiovascular factors in risk of severe cardiovascular events
9. Drug Regimen Prevents AIDS Transmission Via Breast Milk
10. LCA-Vision Announces Upcoming Investment Community Events
11. Large Study Identifies Most Costly Adverse Events in Childrens Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... Treatment Center has added hiking to its options. Already an industry ... Palms is constantly on the lookout for the latest successful trends in helping ...
(Date:7/27/2015)... ... July 27, 2015 , ... At Champagne Smiles, they know that tooth ... can incur a lot of stress, pain, discomfort and embarrassment, which is why they ... treatment reaps the benefits of implants with the cost savings of dentures for anyone ...
(Date:7/27/2015)... ... July 27, 2015 , ... Hexagon Geospatial is ... to understand and share your geospatial experience. These new light-weight applications cohesively combine ... distinct business problems. , “Our world is more dynamic than it has ever ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... Boston IVF, ... birth, will host an educational "Happy Hour" on Nantucket Island for women who ... August 6 at Grey Lady Restaurant and Bar, 2 Chins Way, Nantucket Island 02554 ...
(Date:7/27/2015)... ... 27, 2015 , ... Rountree Brady Insurance Agency, a locally ... new charity drive to support Next Generation, a volunteer group that works to ... , Next Generation workers are dedicated to improving the lives and outlooks of ...
Breaking Medicine News(10 mins):Health News:Hiking Adds Benefits to Recovery at Serenity Palms 2Health News:Hiking Adds Benefits to Recovery at Serenity Palms 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 4Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 2Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 3Health News:Boston IVF to Host Egg Freezing Event in Nantucket on August 6th at 4:30pm 2Health News:Boston IVF to Host Egg Freezing Event in Nantucket on August 6th at 4:30pm 3Health News:Rountree Brady Announces Charity Effort to Support Children’s Services at the Memorial University Medical Center Hospital 2Health News:Rountree Brady Announces Charity Effort to Support Children’s Services at the Memorial University Medical Center Hospital 3
... ... Management Project , ... Chicago (PRWEB) June 11, 2009 -- The Critical Access Hospital (CAH) Quality Network of ... healthcare risk, quality and patient safety software and consulting services have joined forces to ...
... it) more, experts say, , THURSDAY, June 11 (HealthDay News) -- ... shape, all you need is a four-legged pal. , Dr. ... Northwestern University,s Feinberg School of Medicine, said that dogs make great ... are natural exercise machines on a leash," he said. , Research ...
... DENVER, June 11 Birner Dental Management Services, Inc. ... PERFECT TEETH dental practices, announced its regular quarterly ... quarterly cash dividend of 17 cents per share of common ... shareholders of record June 26, 2009. , , Birner ...
... strong record of revenue growth and sales force development , ... Bulletin Board: XELR), a provider of functional foods, beverages and ... for the role of Vice President - Strategy and Network ... of XELR8 said, "We are excited to add Kevin,s strong ...
... , SAN DIEGO, June 11 Orexigen(R) Therapeutics, Inc. ... on the treatment of obesity, today announced the licensing ... expands the Company,s IP position underlying Contrave, its lead ... , "This license agreement with GSK complements the IP ...
... Wis., June 11 Health plan transparency has gained ... "quest" to have better information to make informed health ... quality is often discussed in the form of better ... in reporting on member and claims disruption. The health ...
Cached Medicine News:Health News:North Dakota Critical Access Hospital Quality Network Moves Forward with Statewide Information Management Project to Enhance Patient Safety in the State 2Health News:North Dakota Critical Access Hospital Quality Network Moves Forward with Statewide Information Management Project to Enhance Patient Safety in the State 3Health News:Need a Walking Partner? Try a Dog 2Health News:Need a Walking Partner? Try a Dog 3Health News:XELR8 Holdings, Inc. Hires Vice President of Strategy and Network Development 2Health News:XELR8 Holdings, Inc. Hires Vice President of Strategy and Network Development 3Health News:Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R) 2Health News:Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R) 3Health News:Moving Beyond the Mysteries of Disruption Reporting 2
(Date:7/27/2015)... -- QT Vascular Ltd., together with its subsidiaries ("QT Vascular" ... design, assembly and distribution of advanced therapeutic solutions for ... into an agreement with a group of investors (the ... This funding will strengthen the Group,s working capital which ... Dr. Eitan Konstantino , Ph.D., ...
(Date:7/27/2015)... York , July 27, 2015 ... Research "Bionics Market - Global Industry Analysis, Size, Share, Growth, ... valued at USD 7.96 billion in 2014, growing at a ... USD 20.49 billion in 2021. The global bionics ... number of accidents, which is leading to paralysis or amputation ...
(Date:7/27/2015)... , July 27, 2015 Dynatronics Corporation (NASDAQ: DYNT ... Solaris therapeutic modality products. This approval allows the company to sell ... countries around the world. "Receiving the CE Mark represents ... stated Kelvyn H. Cullimore Jr. , president and CEO of ... network into China , Japan ...
Breaking Medicine Technology:QT Vascular Obtains Funding To Boost Growth Through Issuance of up to US$13.14 Million Convertible Bonds 2QT Vascular Obtains Funding To Boost Growth Through Issuance of up to US$13.14 Million Convertible Bonds 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Dynatronics Awarded CE Mark Approval for Its Solaris Products 2
... trauma or,noise-induced hearing loss. By any name, it,s the ... 28 million Americans,have impaired hearing; for as many as ... December 2007 issue of Harvard Men,s,Health Watch., Acoustic ... exposure,is the most common cause, but recreational noise -- ...
... Proven to Significantly Improve Overall Survival in ... Patients ... 19 ,Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq:,ONXX) today ... a supplemental New Drug Application for Nexavar(R) (sorafenib),tablets for the ...
Cached Medicine Technology:Your Hearing May be at Risk, Says Harvard Men's Health Watch 2Nexavar First FDA-Approved Drug Therapy for Liver Cancer 2Nexavar First FDA-Approved Drug Therapy for Liver Cancer 3Nexavar First FDA-Approved Drug Therapy for Liver Cancer 4Nexavar First FDA-Approved Drug Therapy for Liver Cancer 5Nexavar First FDA-Approved Drug Therapy for Liver Cancer 6
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: